Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Urease-powered nanobots for radionuclide bladder cancer therapy

  • Simó, Cristina|||0000-0002-5980-9379
  • Serra-Casablancas, Meritxell|||0000-0003-4806-3249
  • Hortelão, A. C. L.|||0000-0001-9269-0480
  • Di Carlo, Valerio|||0000-0002-5099-0685
  • Guallar Garrido, Sandra|||0000-0002-9666-5757
  • Plaza-García, Sandra
  • Rabanal Prados, Rosa Ma|||0000-0002-9521-791X
  • Ramos-Cabrer, Pedro|||0000-0003-0368-7031
  • Yagüe, Balbino
  • Aguado, Laura
  • Bardia, Lídia
  • Tosi, Sébastien
  • Gómez Vallejo, Vanessa|||0000-0003-3995-9596
  • Martín, Abraham
  • Patiño, Tania|||0000-0001-9979-7926
  • Julián, Esther|||0000-0002-6558-3978
  • Colombelli, Julien|||0000-0002-2784-4276
  • Llop, Jordi|||0000-0002-0821-9838
  • Sánchez Ordóñez, Samuel|||0000-0001-9713-9997
Bladder cancer treatment via intravesical drug administration achieves reasonable survival rates but suffers from low therapeutic efficacy. To address the latter, self-propelled nanoparticles or nanobots have been proposed, taking advantage of their enhanced diffusion and mixing capabilities in urine when compared with conventional drugs or passive nanoparticles. However, the translational capabilities of nanobots in treating bladder cancer are underexplored. Here, we tested radiolabelled mesoporous silica-based urease-powered nanobots in an orthotopic mouse model of bladder cancer. In vivo and ex vivo results demonstrated enhanced nanobot accumulation at the tumour site, with an eightfold increase revealed by positron emission tomography in vivo. Label-free optical contrast based on polarization-dependent scattered light-sheet microscopy of cleared bladders confirmed tumour penetration by nanobots ex vivo. Treating tumour-bearing mice with intravesically administered radio-iodinated nanobots for radionuclide therapy resulted in a tumour size reduction of about 90%, positioning nanobots as efficient delivery nanosystems for bladder cancer therapy. Bladder cancer treatment suffers from low therapeutic efficacy. Here the authors present radioactive 131 I-labelled urease-powered nanobots that exhibit enhanced accumulation at the tumour site, enabling effective radionuclide therapy at low doses as an alternative treatment option for bladder cancer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries, a systematic review, 2008 to 2023

  • Gogichadze, Nino|||0000-0001-7014-1608
  • Sagrera, Arnau
  • Vicente, José Ángel
  • Millet, Joan Pau|||0000-0003-0200-2459
  • López-Seguí, Francesc
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
Background: In countries with a low TB incidence (≤ 10 cases/100,000 population), active pulmonary tuberculosis (PTB) mostly affects vulnerable populations with limited access to healthcare. Thus, passive case-finding systems may not be successful in detecting and treating cases and preventing further transmission. Active and cost-effective search strategies can overcome this problem. Aim: We aimed to review the evidence on the cost-effectiveness (C-E) of active PTB screening programmes among high-risk populations in low TB incidence countries. Methods: We performed a systematic literature search covering 2008-2023 on PubMed, Embase, Center for Reviews and Dissemination, including Database of Abstracts of Reviews of Effects (DARE), National Health Services Economic Evaluation Database (NHS EED), Global Index Medicus and Cochrane Central Register of Controlled Trials CENTRAL). Results: We retrieved 6,318 articles and included nine in this review. All included studies had an active case-finding approach and used chest X-ray, tuberculin skin test, interferon-gamma release assay and a symptoms questionnaire for screening. The results indicate that screening immigrants from countries with a TB incidence.